Profile picture

Doctor Sayaka Funabashi

Kyorin University, Tokyo (Japan)
Follow
Biography
2005-2011 Kyorin University, Tokyo, Japan 2011-2013 Internship, Kyorin University Hospital, Tokyo, Japan 2013-2016 Cardiology Resident, Kyorin University Hospital, Tokyo, Japan 2016-2019 Cardiology Resident, Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center, Osaka, Japan 2019-2021 Cardiology Fellow, Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center, Osaka, Japan 2021-2022 Cardiology Clinical Fellow, Kyorin University Hospital, Tokyo, Japan 2022- Cardiology Assistant Professor, Kyorin University Hospital, Tokyo, Japan
Logo ESC

Contributor content

Apolipoprotein B and the regression of lipidic plaque in statin-treated type 2 DM patients with coronary artery disease: the pre-specified sub-analysis from the OPTIMAL randomized controlled trial
Presentation
Apolipoprotein B and the regression of lipidic plaque in statin-treated type 2 DM patients with coronary artery disease: the pre-specified sub-analysis from the OPTIMAL randomized controlled trial
The effect of achieving LDL-C <1.8 mmol/L to prevent the first atherosclerotic cardiovascular events in the primary prevention settings of severe heterozygous familial hypercholesterolemia
Presentation
The effect of achieving LDL-C <1.8 mmol/L to prevent the first atherosclerotic cardiovascular events in the primary prevention settings of severe heterozygous familial hypercholesterolemia
Characterization of cholesterol efflux capacity in diabetic and non-diabetic patients with coronary artery disease: comparison between acute coronary syndrome and stable coronary artery disease
Presentation
Characterization of cholesterol efflux capacity in diabetic and non-diabetic patients with coronary artery disease: comparison between acute coronary syndrome and stable coronary artery disease
Lp (a) > 50 mg/dl predicts atherosclerotic cardiovascular events in patients with heterozygous familial hypercholesterolemia who achieved LDL-C < 2.6 mmol/l
Presentation
Lp (a) > 50 mg/dl predicts atherosclerotic cardiovascular events in patients with heterozygous familial hypercholesterolemia who achieved LDL-C < 2.6 mmol/l
Prevalence, clinical characteristics and prognosis of intracranial artery atherosclerosis in heterozygous familial hypercholesterolemia: insights from magnetic resonance angiography imaging analysis
Presentation
Prevalence, clinical characteristics and prognosis of intracranial artery atherosclerosis in heterozygous familial hypercholesterolemia: insights from magnetic resonance angiography imaging analysis
Extensive formation of atherosclerotic cardiovascular disease in subjects with severe familial hypercholesterolemia defined by the international atherosclerosis society criteria
Presentation
Extensive formation of atherosclerotic cardiovascular disease in subjects with severe familial hypercholesterolemia defined by the international atherosclerosis society criteria
Long-term prognostic significance of renal tubular damage, as assessed by urinary Nacetyl-beta-D-glucosamidase, on admission in patients with acute heart failure
Presentation
Long-term prognostic significance of renal tubular damage, as assessed by urinary Nacetyl-beta-D-glucosamidase, on admission in patients with acute heart failure

ESC 365 is supported by